SurveyInterleukin-8 and human cancer biology
Section snippets
IL-8 expression
IL-8 was originally identified as a neutrophil chemotactic factor in the supernatants of activated human monocytes. As a member of the CXC chemokine family, IL-8 plays an important role as an activator and chemoattractant for neutrophils. The initial observation of IL-8 expression was done in human melanocytes and malignant melanoma cell lines stimulated with either TNF-α or IL-1α, the IL-8 mRNA signal corresponded well with the amount of secreted IL-8 protein [20]. It was predicted that IL-8
Regulation of IL-8 expression
It is now known that IL-8 is produced by various normal and tumorigenic human cells. While the production of IL-8 can be induced by various stimuli, such as lipopolysaccharide, phorbol 12-myristate 13-acetate (PMA), IL-1, and TNF (Fig. 1) [77], [78], [79], [80], [81], many tumor cells apparently express IL-8 constitutively. Furthermore, we have found that several stress factors, such as hypoxia, acidosis, nitric oxide (NO), and cell density, significantly influence the expression of IL-8 in
IL-8 expression and cancer progression
As a potential prognostic factor, IL-8 expression has been investigated in clinical studies using patient tumor tissue specimens and preclinical animal models using established cell lines. In human pancreatic cancer, IL-8 is overexpressed in tumor tissue as compared with normal tissue. To determine the role of IL-8 expression in tumor growth and metastasis, we used an orthotopic xenograft model to evaluate the tumorigenic and metastatic potential of COLO357, FG, SG, and L3.3 cells, which were
IL-8 and mitogenic effect
Since the discovery of IL-8 production by tumor cells, it has been predicted that IL-8 may stimulate tumor growth [20]. Schadendorf et al. [48] first demonstrated that endogenously produced human IL-8 can act as an important growth factor for human melanoma cells. They found that human melanoma cell lines secrete significant amounts of bioactive IL-8 protein into the culture supernatant and that this secretion was inducible by IL-1 and PMA. Exposure of some human melanoma cell lines in vitro to
IL-8 and angiogenic effect
The angiogenic activity of IL-8 produced by monocytes and macrophages was first demonstrated by Koch et al., [142] in 1992. They found that human recombinant IL-8 was potently angiogenic when implanted in a rat cornea and induced proliferation and chemotaxis of human umbilical vein endothelial cells. The angiogenic activity present in the conditioned medium of inflamed human rheumatoid synovial tissue macrophages and lipopolysaccharide-stimulated blood monocytes was equally blocked by
IL-8 and motogenic effect
IL-8 is a physiological initiator of the chemotactic migration of leukocytes, e.g. neutrophils and macrophages. Overexpression of IL-8 by tumor cells may lead to elevated infiltration of leukocytes, which have been shown to potentially produce various growth factors and angiogenic factors in large quantities and rapid expansion of tumor mass. The tumor cell-initiated and tumor infiltration cell-mediated tumor angiogenesis may produce strong indirect tumor-stimulating effects and underscore the
Targeting IL-8 expression for cancer treatment
The role of IL-8 in the growth and metastasis of some types of cancer, including human pancreatic adenocarcinoma, makes IL-8 an attractive target for treatment of cancer. A direct strategy may be to use an IL-8-neutralizing antibody to interfere with the functions of IL-8. Alternatively, blocking the IL-8 receptors will also block the signal transduction pathway initiated by IL-8. Additionally, there are two receptors for IL-8: IL-8Rα, which is specific for IL-8, and IL-8Rβ, which also binds to
Conclusion and future directions
The development of multiple autocrine growth-signaling pathways renders tumor cells a tremendous growth advantage and imposes significant difficulties in designing effective cancer therapy. Adding to the long list of growth factors and cytokines, IL-8 may also play a role in human cancer progression. The inference of the impact of IL-8 expression on tumor growth requires combined consideration of data obtained from cell cultures, animal models, and clinical studies. Nevertheless, multiple
Acknowledgements
I thank Don Norwood for editorial comments and Judy King for assistance in the preparation of this manuscript. This work was supported by the Research Project Grant #RPG-00-054-01-CMS from the American Cancer Society, the Lustgarten Pancreatic Cancer Research Foundation, the Multidisciplinary Pancreatic Program Research Grant, and Cancer Center Support Core grant CA 16672-23 form the National Institutes of Health (to Keping Xie).
References (178)
Role of growth factors in pancreatic cancer
Surg. Oncol. Clin. North Am.
(1998)- et al.
Interleukin (IL)-6 as a pancreas carcinoma-derived vascular permeability regulator in vitro
Pathol. Res. Pract.
(1996) - et al.
Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions
J. Biol. Chem.
(1991) - et al.
Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells
J. Invest. Dermatol.
(1991) - et al.
Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro
Cytokine
(2000) - et al.
Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer
Gynecol. Oncol.
(1999) - et al.
Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene
J. Biol. Chem.
(1992) - et al.
Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung
Cancer Lett.
(1997) - et al.
Angiogenesis in mesotheliomas. Role of mesothelial cell derived IL-8
Chest
(1996) - et al.
Regulation of interleukin-8 gene expression by all-trans retinoic acid
Biochem. Biophys. Res. Commun.
(1995)
Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas
Hum. Pathol.
The chemotactic cytokine interleukin-8—a cyst fluid marker for malignant epithelial ovarian cancer?
Gynecol. Oncol.
Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells
Urology
Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer
Urology
Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF
Cytokine
Interleukin-8 and the chemokine family
Int. J. Immunopharmacol.
Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level
Biochem. Biophys. Res. Commun.
Up-regulation of interleukin-1beta-stimulated interleukin-8 in human keratinocytes by nitric oxide
Biochem. Pharmacol.
Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness
Am. J. Pathol.
Cancer of the pancreas
Advances from genetic clues in pancreatic cancer
Curr. Opin. Oncol.
Experimental Animal Models for Pancreatic Cancer
Int. J. Oncol.
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
Cancer Res.
Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression
Clin. Cancer Res.
Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors
Cancer Res.
Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage
Cancer Res.
Expression of basic fibroblast growth factor (FGF-2)-associated with tumour proliferation in human pancreatic carcinoma
Virchows Arch.
TGF-beta-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor
Int. J. Cancer
The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer
Oncogene
Cytokines modulate MIA PaCa-2 and CAPAN-1 adhesion to extracellular matrix proteins
Pancreas
Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells: a possible event in tumor regression
Int. J. Cancer
Constitutive and inducible interleukin-8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic
Clin. Cancer Res.
Regulation of interleukin-8 expression by cellular pH in human pancreatic adenocarcinoma cells
J. Interferon Cytokine Res.
Cooperation between transcription factor AP-1 and NF-κB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia
J. Interferon Cytokine Res.
Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma
J. Interferon Cytokine Res.
Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia
Ann. Hematol.
Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein
Blood
Induction and regulation of IL-8 and MCAF production in human brain tumor cell lines and brain tumor tissues
Eur. Cytokine Network
Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumors
Int. J. Cancer
The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours
Mol. Pathol.
Characterization of GRO alpha, beta and gamma expression in human colonic tumours: potential significance of cytokine involvement
Surg. Oncol.
Interleukin-8 has antitumor effects in the rat which are not associated with polymorphonuclear leukocyte cytotoxicity
Cancer Immunol. Immunother.
Interleukin-8 as a growth factor for human colorectal carcinoma cells in vitro
Biochem. Soc. Trans.
Expression of interleukin-8 correlates with vascularity in human gastric carcinomas
Am. J. Pathol.
Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice
Br. J. Cancer
In vitro differentiation of a Hodgkin's disease derived cell line
Hematol. Oncol.
Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells
Cancer Res.
Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma
J. Exp. Med.
Spontaneous production of interleukin-8 by human lung cancer cells and its augmentation by tumor necrosis factor alpha and interleukin-1 at protein and mRNA levels
Oncology
Role of C–X–C chemokines as regulators of angiogenesis in lung cancer
J. Leukocyte Biol.
Cited by (625)
Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds
2024, International ImmunopharmacologyChemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact
2022, Seminars in Cancer BiologyFeiyanning downregulating CXCLs/CXCR2 axis to suppress TANs infiltration in the prevention of lung cancer metastasis
2022, Journal of EthnopharmacologyCitation Excerpt :CXCL8 mediates function by activating two receptors, CXCR1 and CXCR2. ( Fousek et al., 2021; Xie, 2001). CXCR2 appears to be the predominant receptor mediating its chemotactic response, which is involved in human CXC chemokines CXCL1, CXCL2, CXCL3, CXCL4, CXCL5, CXCL6, CXCL7, and CXCL8 expression. (